Search

Filters
Clear All
  • 12
  • 19
  • 90

Phase

  • 6
  • 8
  • 20
  • 2
  • 25
  • 1
  • 57
  • 120
  • 20

Found 121 will-simon trials

A listing of will-simon medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

S
Suparna C. Clasen, MD, MSCE
100 years or below
All genders
What is the purpose of this study?The purpose of this study is to determine the incidence and characterize the nature of cardiovascular adverse events occurring following CAR T-cell therapy, including arrhythmia, cardiac ischemia, myocarditis, and heart failure, and the therapeutic modalities used to treat these cardiovascular events. THIS STUDY IS …
 ARE YOU A BREAST CANCER SURVIVOR?  Join Our Study and Help Researchers Learn More About Treating Cognitive Problems Attributed to Chemotherapy
B
Brenna McDonald
18 years - 100 years
Female
ARE YOU A BREAST CANCER SURVIVOR?  HAVE YOU NOTICED ANY PROBLEMS WITH YOUR COGNITIVE FUNCTION - MEMORY, ATTENTION, ABILITY TO MULTI-TASK - AFTER COMPLETING CHEMOTHERAPY? Researchers at Indiana University School of Medicine and the University of Pittsburgh are seeking volunteers to take part in a study looking at two telehealth-delivered therapies …
H
Huda Salman
18 years - 100 years
All genders
Researchers as the Indiana University Simon Comprehensive Cancer Center are conducting a study to research the safety and effectiveness of increasing doses of CD4CAR T cell therapy for patients who have been diagnosed with, or are being treated for, relapsed or refractory (has not responded to treatment) CD4+ chronic myelomonocytic …
T
Tarah Ballinger, MD
18 years - 100 years
Female
What is the purpose of this study?The purpose of this study is to assess the feasibility of the NearWave optical molecular monitoring system for monitoring therapy progression and predicting pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy (NAC). THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with …
L
Larry Cripe, MD
18 years - 100 years
All genders
What is the purpose of this study?To characterize the way in which oncologists, oncology nurses, and oncology pharmacists evaluate the treatment options for patients with CLL/SLL and engage or support patients in shared decision-making.To test the acceptability and usability of the interactive web-enabled communication and decision-making resources of the CLL/SLL …
M
Mateusz Opyrchal, MD, PhD
18 years - 100 years
All genders
Phase 1/2
What is the purpose of this study?Phase 1a Dose Escalation/Cohort Expansion BBO-10203 Monotherapy Primary: To evaluate the safety and tolerability of BBO-10203, an inhibitor of the PI3Kα:RAS interaction, in subjects with locally advanced unresectable or metastatic (ie, advanced) HER2-positive BC; HR-positive, HER2-negative BC; KRAS mutant NSCLC; and KRAS mutant CRC. Secondary: To evaluate …
O
Omar Ishaq
18 years - 100 years
Male
What is the purpose of this study?The purpose of this study is to evaluate the tolerability and toxicity of combining two radiation therapy methods. Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is an external beam radiotherapy with High Dose Rate Brachytherapy Boost (form of internal radiation where a cancer …
C
Carla Fisher, MD
18 years - 100 years
All genders
Phase 1
What is the purpose of this study?This is a multicenter, first-in-human (FIH), open label, Phase 1 dose escalation and recommended Phase 2 dose (RP2D) extension trial with a primary objective to define the RP2D of SRG-514 when administered intraoperatively to patients undergoing breast-conserving cancer surgery. SRG-514 will be investigated utilizing …
G
Greg Durm, MD
18 years - 100 years
All genders
Phase 1
To assess the safety and tolerability of TTX-080
M
Mohammad Abu Zaid, MD
18 years - 65 years
Male
Observational
The purpose of this study is to compare men who were treated for testicular cancer and received high dose cisplatin-based chemotherapy and peripheral blood stem cell transplant to those who received conventional doses of cisplatin-based chemotherapy for treatment of the same disease and men who have never been diagnosed with …